Inactive Instrument

Company Response Oncology, Inc. Other OTC

Equities

ROIX

US7612323052

Healthcare Facilities & Services

Business Summary

Response Oncology, Inc. was, prior to the sales of its assets, a comprehensive cancer management company. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.

Sales per Business

USD in Million2000Weight2001Weight Delta
Physician practice management
56.4 %
78 59.4 % 67 56.4 % -14.23%
Impact services
43.4 %
53 40.2 % 51 43.4 % -2.51%
Cancer research services
0.2 %
1 0.4 % 0 0.2 % -67.46%

Sales per region

USD in Million2000Weight2001Weight Delta
United States
100.0 %
131 100.0 % 118 100.0 % -9.74%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,178,701 12,100,000 ( 99.35 %) 0 99.22 %
Stock B 0 16,631 0 0

Company contact information

Response Oncology, Inc.

1805 Moriah Woods Boulevard

38117, Memphis

+

address Response Oncology, Inc.(ROIX)
  1. Stock Market
  2. Equities
  3. ROIX Stock
  4. ROIX Stock
  5. Company Response Oncology, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW